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Background: In this study, we investigated the effect of the extracellular matrix on endothelial dysfunction by
careful observation of human umbilical vein endothelial cells (HUVECs) cultured on denatured collagen film.
Results: HUVECs on denatured collagen film showed relatively high surface roughness compared with normal
HUVECs. The expression levels of MMP-1, MMP-2 and CD146 increased in the ECs on denatured collagen film. In
addition, we examined the accumulation of fluorescent beads on HUVEC layers subjected to circulatory flow. The
number of accumulated fluorescent beads increased on the disorganized HUVEC layers.
Conclusions: The proposed in vitro study using bio-inspired collagen films could potentially be used in the
size- and ligand-based design of drugs to treat endothelial dysfunction caused by circulatory vascular diseases.Background
Atherosclerosis is a major cause of morbidity and mor-
tality [1]. Many in vitro experiments on the early devel-
opment stage of atherogenesis have been performed
using pro-inflammatory mediators, such as lipopolysac-
charide in bacterial cell walls [2-9], as stimuli. Endothelial
cell (EC)-leukocyte interaction of these stimuli induces
changes in shape, permeability, and gene expression of
ECs [10-13]. However, previous studies overlooked the
effects of the extracellular matrix (ECM) on variations
in morphology and growth of ECs. Thus, this study ex-
perimentally investigated the effect of ECM properties
on endothelial dysfunction.
The EC layer functions as an interface between circulat-
ing blood and surrounding tissues [14,15]. ECs modulate
thrombosis and inflammation, and control mural smooth
muscle cells and vascular health. These cells also function
in physiological processes, such as innate and adaptive im-
mune responses. Thus, endothelial dysfunction is associ-
ated with the development of atherosclerosis and other* Correspondence: sjlee@postech.ac.kr
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unless otherwise stated.cardiovascular disorders [16-18]. ECM degradation, which
is possibly regulated by matrix-degrading metallopro-
teinases (MMPs) and their endogenous tissue inhibitors,
is closely involved in the outbreak of atherogenesis [19-21].
MMPs belong to a family of zinc metalloendopeptidases.
These enzymes, which degrade ECM proteins, exhibit im-
portant functions in embryo development, morphogenesis,
and tissue remodeling, as well as in various diseases,
such as arthritis, atherosclerosis, invasion, and metastasis
of cancer cells [22]. A maximum of 25 MMP members are
found in humans and animals. Among these MMPs, 14
are related to atherosclerosis [23]. Vascular cells, including
ECs and macrophages, secrete MMPs. ECs also express
MMP-1 (collagenase), MMP-2 (gelatinase), and MMP-3
(stromelysin) [24-26].
The mechanical properties of arterial walls and suscepti-
bility to pathological vascular remodeling are mainly
determined by the macromolecular structures of collagen,
elastin, and proteoglycans [27-29]. Under low pressure,
the high compliance of elastin dominates the wall
displacement. At high pressure, the wall displacement
is limited by the stiffer collagen. Degradation of these
mechanical properties with aging [30], smoking [31],
diabetes [32], hypertension [33], and atherosclerosis
[29,34] is associated with changes in the collagen and
elastin scaffold. Although these macromolecules gener-
ate the biphasic mechanical response of arterial walls. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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remain as a missing element in the modeling of wall
mechanics [35,36]. Therefore, we hypothesized that the
structural change in collagen by MMP-1 and MMP-2
expression may induce endothelial dysfunction, such as
disorganization and thickening of the EC layer. To val-
idate this hypothesis, we prepared two different collagen
films as ECM models. The normal collagen film corre-
sponded to the ECM of normal blood vessels, and the
denatured collagen film was adopted to mimic the ECM
of atherosclerotic blood vessels. The denatured collagen
film was intentionally disrupted by collagenase treatment
to simulate the denatured ECM by increasing MMP-1 and
MMP-2 expression under in vivo conditions. Through
preliminary experiments using zebrafish models for inves-
tigating the early development stage of atherogenesis, we
observed an EC monolayer surrounded by a collagen
basement membrane in the normal vascular endothe-
lium. The vascular endothelium of the early develop-
ment stage of atherogenesis shows the disorganization
and thickening of the EC layer [37]. To simulate these
morphological results, we cultured human umbilical
vein endothelial cells (HUVECs) on two different types
of collagen films.
In this study, morphological variations in the bio-inspired
ECM were experimentally investigated. The spatial dis-
tribution of surface roughness of ECs on the ECM was
observed by phase-contrast digital holographic micros-
copy (DHM). Biological specimens, such as living cells,
are transparent. However, transparent biological samples
are difficult to observe clearly by bright-field microscopy.
Therefore, non-invasive high-resolution imaging of living
cells under in vivo conditions is important to visualize
biological processes. Interferometry-based DHM can be
performed to determine the spatial distributions of the
phase and optical path length of a test sample. This
technique can also provide quantitative phase information
of a sample with a spatial resolution of tens of nanometers
[38-41]. Temporal variations in morphological structure
and EC layer thickness can be clearly observed with a
time-resolved DHM technique.
To study the mechanism of endothelial dysfunction,
we investigated the expression of CD146, vascular cell
adhesion molecule (VCAM), and E-selectin on the sur-
face of abnormal ECs. These three molecules are used
as biomarkers of EC injury [6,17,42-45]. We also exam-
ined the positional information of vascular endothelial
cadherin (VE-cadherin) of ECs. VE-cadherin has an im-
portant function in controlling vascular organization
and modulating endothelial permeability [46].
To develop an optimal delivery system for vascular
targeting and maximize drug accumulation on the EC
layer while avoiding entrapment in the lung and small
capillaries [47], the specific ligand-receptor interactionwith the vessel walls [48] and surface properties related
to specific vascular adhesion and reduced macrophage
uptake should be investigated. To establish an in vitro
study for drug screening of circulatory diseases, fluores-
cent bead accumulation on EC layers was examined
under circulating flow conditions.
Results
Collagen film and denatured collagen film
Figures 1A and 1D illustrate the collagen and dena-
tured collagen films coated on octadecyltrichlorosilane
(OTS)-self-assembled monolayer (SAM)-treated cover-
slips. Figures 1B and 1E show typical scanning electron
microscopy (SEM) images (1000×) of HUVECs on the
collagen and denatured collagen films, respectively. The
surface structures of the two films were also observed
using atomic force microscopy (AFM). Figures 1C and 1F
are typical AFM images showing the morphological
structures of the collagen and denatured collagen
films, respectively. As shown in Figures 1B and 1C, the
collagen film had fiber structures. However, the fibers
were broken in the collagenase-treated collagen film
(Figures 1E and 1F).
Roughness of ECs
The spatiotemporal thickness profiles of HUVECs cul-
tured on collagen film (Figure 2A) or denatured colla-
gen film (Figure 2B) were quantitatively analyzed. The
biophysical properties of HUVECs grown on normal or
enzyme-degraded collagen films were measured using
phase-contrast DHM (Figure 2C). The typical phase-
contrast DHM images in Figures 2D and 2E show the
spatial distributions of the physical thickness of HUVECs
cultured on collagen and denatured collagen films,
respectively. We evaluated the surface roughness of
HUVECs using phase-contrast DHM images. The surface
roughness of ECs was represented mathematically using
the root mean square (RMS) value of its fluctuations. The
HUVECs initially seeded on the collagen film and dena-
tured collagen film exhibited relatively low RMS values.
Figure 2F shows that the RMS value of HUVECs cultured
on collagen film slightly increased after 6 h, and then
rapidly decreased in the time period (t) from 6–24 h.
This result was attributed to normal cell adhesion to the
ECM substrate. The average RMS value was approxi-
mately 3.6 μm (S.D. = 0.8) 24 h after initial seeding. This
value corresponded to an approximate reduction of 59%
from the initial RMS value (6.1 ± 2.3). The surface
roughness of HUVECs cultured on collagenase-treated
collagen film for 5 min gradually increased until t = 24 h
after HUVEC seeding. The RMS value increased by ap-
proximately 178% at t = 24 h compared with the initial
value (4.5 ± 1.9) at t = 1 h. The surface roughness of
HUVECs cultured on collagenase-treated collagen film
Figure 1 Two collagen films prepared for the in vitro study. (A) Normal collagen film, which mimics the ECM of normal blood vessels.
Typical SEM image (B) and AFM image (C) of the collagen film. (D) Denatured collagen film, which mimics the ECM of abnormal blood vessels.
The structure of the denatured collagen film was intentionally broken using collagenase to simulate the abnormal ECM. Typical SEM image
(E) and AFM image (F) of the denatured collagen film.
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with those treated with collagenase for 5 min, and then
gradually decreased as the cells detached from the ECM
substrate after 6 h. The RMS value increased to 300%
at t = 3 h compared with the initial value (4.0 ± 1.7) at
t = 1 h, and decreased by approximately 255% at t = 24 h.
The RMS value of HUVECs cultured on normal collagen
films decreased after 24 h of seeding because the cells ad-
hered to the ECM substrate. By contrast, the RMS values
of HUVECs cultured on collagen films treated with
collagenase for 5 min increased because of abnormal
cell deformation. The surface roughness of HUVECs
on collagen films treated with collagenase for 15 min
increased more rapidly than those treated for 5 min.
However, the RMS value decreased after 12 h because
the abnormally clustered cells were detached from the
ECM substrate.
Cell migration
We established two different collagen films as ECM
models: the collagen film, which had a fiber structure
similar to that of the ECM of normal blood vessels, and
the denatured collagen film, which mimicked the ECM
of atherosclerotic blood vessels. To observe the dynamic
behaviors of cell-to-cell interactions, we cultured HUVECs
on the collagen and denatured collagen films. Dynamic
motions of ECs were observed using confocal laserscanning microscopy (CLSM). ECs cultured on collagen
film or denatured collagen film were mounted in the
flow chamber. Figures 3A and 3B show that ECs on the
normal collagen film (non-treatment group) formed a
monolayer, whereas those found on the denatured colla-
gen films (treatment group) were aggregated and multi-
stacked. Their movements were detected for 90 min at an
interval of 10 min using CLSM. For the time-resolved
tracking of ECs, cell movement was systematically ana-
lyzed by tracking the nuclei of cells. We marked the center
of the nucleus of each cell to track its trajectory. The cir-
cular plots shown in Figures 3C and 3D represent the dir-
ection angle of cell migration and number of distributed
cells on the collagen film and denatured collagen film. All
cells were positioned at the zero point of the starting time,
but these cells spread out as time progressed. As shown
in the circular plots, ECs on the collagen films moved
radially outward in all directions almost evenly. How-
ever, cells on the denatured collagen film moved in a pref-
erential direction. Therefore, the non-treatment group
showed a monolayer, whereas the treatment group exhib-
ited aggregated ECs.
Growth properties of ECs
To compare the proliferation and survival of HUVECs
between the two groups, DNA damage, apoptosis, and cell
proliferation were analyzed using fluorescence-activated
Figure 2 Surface roughness of HUVECs cultured on the two collagen films. HUVECs were incubated on top of the collagen film (A) and
denatured collagen film (B). Surface roughness of HUVECs on the two collagen films was analyzed using phase-contrast DHM. (C) Experimental
setup of the phase-contrast DHM and cell-substrate samples used in this study. (D and E) Spatial distribution of physical thickness of HUVECs on
the normal collagen film (non-treatment group) and denatured collagen film (treatment group). Holograms exhibit the thickness distribution of
HUVECs in the non-treatment group (D) and treatment group (E). (F) Temporal variations in surface roughness of HUVECs cultured on the collagen
film and collagenase-treated collagen film. RMS = root mean square. N = 10.
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(HUVECs on the collagen film) and treatment group
(HUVECs on the denatured collagen film treated with
collagenase for 5 min) were cultured for 6, 12, 24, and
36 h. As shown in Figures 3A–3D, cells with DNA
damage (H2AX-positive population) and apoptosis
(PARP-positive population) were not observed for both
groups. H2AX-negative cells (Figures 4A and 4B) and
PARP-negative cells (Figures 4C and 4D) did not shownoticeable differences on both films. Furthermore,
HUVECs on the denatured collagen film enhanced the
proliferation rate compared with the control group
(Figures 4E–4L). These results show that the aggre-
gated form of HUVECs on the denatured collagen film
was caused by the selective migration of HUVECs into
a specific area or by enhanced proliferation of HUVECs in
a specific area, such as the remaining collagen fibers in
the denatured collagen film.
Figure 3 Confocal images of HUVECs cultured on the two collagen films. (A) Confocal images of HUVECs cultured on the collagen film
(non-treatment group). (B) Confocal images of HUVECs cultured on the collagenase-treated collagen film (treatment group). Circular plots of the
migration angle and number of HUVECs for the non-treatment group (C) and treatment group (D). Scale bar = 100 μm.
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HUVECs were transfected with MMP-1/enhanced green
fluorescent protein (EGFP) and MMP-2/mCherry vectors
to visualize the secretion of MMP-1 and MMP-2. Cells
were cultured on normal (non-treatment group) and
denatured collagen films (treatment group) for 24 h.
These cells were then fixed with paraformaldehyde so-
lution, and stained with 4’,6-diamidino-2-phenylindole
(DAPI, blue). Figure 5A shows that MMP-1 and MMP-
2 were not expressed in the non-treatment group. As
shown in Figure 5B, MMP-1 and MMP-2 were observed
in the treatment group. These results indicate that ECs
on the denatured collagen film could secrete MMP-1
and MMP-2.
Collagen zymography
MMP is secreted as a pro-enzyme, and only activated
MMP can degrade the collagen matrix. Therefore, im-
munofluorescent images do not show MMP activity. To
overcome this limitation, we performed substrate activityusing collagen zymography assay. As shown in Figure 6A,
collagen zymography showed three distinct MMP bands.
The lower band was MMP-1, which was about 40–
60 kDa. The middle band was gelatinase-A (MMP-2),
which was about 72 kDa. The upper band represented
gelatinase-B (MMP-9), which was at about 95 kDa. The
MMP-1 level decreased in the 5 min group compared
with that in the control group (Figure 6B), and further
decreased in the 15 min group. By contrast, the levels of
MMP-2 and MMP-9 increased in the 5 min group com-
pared with those in the control group. However, they
significantly decreased in the 15 min group.
Expression of E-selectin, VCAM, CD146, and VE-cadherin
The expression levels of E-selectin, VCAM, CD146, and
VE-cadherin on the EC surface for the two collagen
films were visualized using immunostaining method and
confocal imaging technique. Among the four adhesion
molecules, CD146 and VE-cadherin were expressed on
the EC surface cultured on both collagen films (Figure 7).
Figure 4 Survival and proliferation of HUVECs. HUVECs were cultured on both films for 6, 12, 24, and 36 h. DNA damage, apoptosis, and cell
proliferation of HUVECs plated on the collagen-treated film were analyzed using flow cytometry to investigate their survival and proliferation.
Comparison of histograms of H2AX-negative cells [(A) and (B), non-DNA damage] and PARP-negative cells [(C) and (D), non-apoptosis] on the
normal collagen film (non-treatment group) and denatured collagen film (treatment group). Cell death by DNA damage (positive population of
H2AX) and apoptosis (positive population of PARP) was not detected. (E–L) Comparison of HUVECs on the collagenase-treated collagen film
showed enhanced proliferation rates.
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creased on the EC surface of the denatured collagen film
compared with that on ECs cultured on normal collagen
film (Figure 7E). The results from the present in vitro
studies on the cultured ECs suggest the important func-
tion of the biophysical properties of ECM in the forma-
tion of the EC layer. In particular, MMP-1 and MMP-2
caused weak cell interactions. Therefore, CD146 expres-
sion increased on the EC surface of the denatured colla-
gen film.Bead accumulation on the EC layer
ECs cultured on the collagen film or denatured
collagenase-treated collagen film for 24 h were mounted
on the flow chamber. The dynamic motion of beads on
the cultured ECs was observed by time-lapse micros-
copy. Weakly adhered beads were detached under flow
conditions, and some beads attached to the HUVEC
layer were continuously concentrated to form EC clus-
ters. In HUVECs cultured on the collagen film and de-
natured collagen film for 24 h, the size and number of
Figure 5 MMP-1 and MMP-2 of HUVECs. Bright field (gray), nucleus (blue), MMP-1/EGFP (green), and MMP-2/mCherry (red) images of normal
(A) and abnormal HUVECs (B) cultured for 24 h. Scale bar = 100 μm.
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rate increased. The beads were clustered on the HUVEC
layers, and the cluster size increased. Figures 8A and 8B
show the confocal images captured after 1 min at a flow
rate of 1 mL/h. Figures 9A–9D show the fluorescence
images captured after 1 min at the same flow rate. As
shown in these figures, the beads on the normal EC
layer (Figures 6A, 7B, and 9A) were less accumulated
than those on the abnormal EC layers (Figures 8B, 9C,
and 9D). In addition, the clusters in the treatment groupFigure 6 Comparison of the activities of MMP-1, −2, and −9 in HUVEC
cultured for 24 h. (A) Collagen zymography. (B) Densitometric analysis of M
film; 5 min, HUVECs on the denatured collagen film treated with collagena
with collagenase for 15 min. N = 3.were larger than those in the non-treatment group.
Figures 9E and 9F show the temporal variations in the
number of clusters and in the sum of cluster areas, re-
spectively. These values were obtained from time-lapse
images recorded consecutively at a flow rate of 1 mL/h. In
Figure 9E, the number of clusters gradually increased, and
the number of clusters on the normal EC layer was lower
than that on the abnormal EC layer. Figure 9F shows that
the beads on the normal EC layer were less accumulated
than those on the abnormal EC layer. The slope increaseds. MMP activity measured by collagen zymography for HUVECs
MP-1, −2, and −9 activity in HUVECs. Control, HUVECs on the collagen
se for 5 min; 15 min, HUVECs on the denatured collagen film treated
Figure 7 Comparison of the expression of E-selectin, VCAM, CD146, and VE-cadherin. HUVECs cultured for 24 h on the collagen film
(A, C, E, and G) and denatured collagen film treated with collagenase for 5 min (B, D, F, and H). Fluorescence images of actin [red in (G) and
(H), green in other figures], nucleus (blue), adhesion molecules (green in VE-cadherin and red in E-selectin, VCAM, and CD146), and their merged
images. E-selectin (A, B), VCAM (C, D), CD146 (E, F), and VE-cadherin (G, H). Scale bar = 250 μm.
Figure 8 Confocal images of beads accumulated on the HUVEC layers. (A) Accumulated beads (green) on the normal HUVEC layer
(non-treatment group). (B) Accumulated beads (green) on the abnormal HUVEC layer (treatment group). The images were captured after 1 min
under a flow rate of 1 mL/h (shear stress: 23.96 mPa). White arrows indicate the direction of medium flow, and red arrows in (B) denote the bead
clusters accumulated near the HUVEC clusters. The cross-sectional profiles are displayed along the yellow lines in the right ends and bottom parts.
Scale bar = 100 μm.
Seo et al. BMC Biotechnology 2014, 14:61 Page 8 of 16
http://www.biomedcentral.com/1472-6750/14/61
Figure 9 Bead accumulation on HUVECs cultured on the two collagen films. Fluorescent images of accumulated beads (green) on the
normal (A and B) and abnormal HUVEC (red) layers (C and D). The images were captured after 1 min under a flow rate of 1 mL/h (shear stress:
23.96 mPa). The images in the yellow dotted box were magnified two times (B and D). Scale bar: 100 μm. (E and F) Temporal variations in the
number of clusters (E) and sum of cluster areas (F).
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compared with that for the normal EC layer group. In
addition, the sum of cluster area in the collagenase-treated
group was higher than that of the non-treatment normal
group. The slope was higher (18.8%) for the abnormal EC
layer group than that for the normal EC layer group.Discussion
In this study, the expression levels of MMP-1 and
MMP-2 were observed in ECs on denatured collagen
film. The results show that the destruction of the ECM
structure was caused by MMP-1 and MMP-2, which
was secreted by ECs on denatured collagen film. In
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mation of EC clusters and detachment of EC clusters
from the EC layer. The experimental results obtained
from the present in vitro studies on the cultured ECs
suggest that the biophysical properties of ECM had an
important function in the formation of the EC layer.
Only HUVECs grown on the denatured collagen film
expressed MMP-1 and MMP-2, whereas no MMP ex-
pression was found in HUVECs grown on the collagen
film. Previous studies have shown that HUVECs grown
on collagen gels express MMP-1, −2, and MT1-MMP to
degrade the collagen matrix [49,50]. Consequently, MMP
expression is higher on stiffer matrix (collagen film) com-
pared with that on softer matrix (denatured collagen film)
[51,52]. Given that MMP is secreted as a pro-enzyme
(pro-MMP) and only activated MMP can degrade the
collagen matrix, immunofluorescent images do not show
much about MMP activity [53,54]. The collagen zymogra-
phy data obtained in this study show that HUVECs on the
three different collagen films had relatively different MMP
activities. Zymography is an electrophoretic technique
to detect hydrolytic enzymes based on the substrate
repertoire for the enzyme. Collagen zymography allows
us to examine MMP activity, whereas fluorescence im-
ages of MMP in Figure 5 distinguish whether the MMP
is present or not. Thus, the fluorescence images show-
ing the expression of MMPs in Figure 5 are different
from the zymography data showing the activity of MMPs
in Figure 6.
HUVECs adhered to the collagen films during collagen
zymography, but the experimental results do not reflect
the entire endothelium. To overcome this limitation, fur-
ther collagen zymography experiments using detached
ECs (circulating ECs) or MMPs secreted by ECs are
required in the future.
All the experiments were performed by culturing ECs
on the collagen films for up to 24 h. At 24 h after seeding
of ECs, HUVECs clustered on the denatured collagen
films gradually detached from the substrate. Given the
difficulty in quantitatively analyzing the cells because of
their complexity, we only carried out the experiments
for up to 24 h.
Among several adhesion molecules, CD146 expression
significantly increased on the EC surface of the dena-
tured collagen film compared with that on ECs cultured
on normal collagen film. The adhesion molecules of
ECs possibly modulated gene expression by changing the
morphological structures of the ECM by MMP-1 and
MMP-2. These molecules may activate many signaling
molecules in focal adhesion and cytoplasm by dynamically
interacting with ECM proteins. The denatured ECM may
cause endothelial dysfunction by mechanotransduction
mechanisms. CD146 is a marker for circulating endothe-
lial cells. The increased levels of CD146 are positivelycorrelated with active inflammatory reactions in idio-
pathic myopathy [55], chronically inflamed tissues [56],
inflammatory skin disease [57], rheumatoid arthritis
[58], inflammatory bowel disease [59,60], chronic ob-
structive pulmonary disease [61], and multiple sclerosis
disease [62,63]. The engagement of CD146 initiates the
protein kinase phosphorylation cascade through associ-
ation with Fyn, a Src family kinase. Phosphorylated Fyn
subsequently transfers phosphate to the downstream
kinase of PKC-γ, which triggers a Ca2+ burst within cells.
Consequently, the induced association among proteins of
P130, Pyk2, and paxillin, as well as activated p125 (FAK),
promotes the polarization actions of actins. Thus, this
CD146-mediated signaling pathway can be used to de-
cipher the mechanism that CD146 promotes cell motil-
ity through extracellular signals to downstream-signaling
components for cytoskeleton remodeling [64,65]. The
integrins of ECs may activate many signaling molecules
in focal adhesion and cytoplasm via dynamic interaction
with collagen fibers. Therefore, the mechanical proper-
ties of denatured collagen fibers may contribute to the
preferential EC migration on the denatured collage film.
For better understanding of its function in signaling
transduction, further study on the crosstalk with mem-
bers of various signaling pathways is required [66].
The functional assessment of ECs can be used to iden-
tify endothelial damage and predict cardiovascular risks.
However, this type of assessment does not provide suffi-
cient information about the mechanisms underlying the
development of endothelial dysfunction [67,68].
In this study, the flow rates used for bead accumulation
experiment do not fully reflect the in vivo pathophysio-
logical conditions. To select effective drugs for circulatory
vascular diseases, the size and surface properties of the
test drugs and flow condition (flow rate or low endothelial
shear stress) of microfluidic devices are highly important.
In particular, the physical dimensions of the microfluidic
devices used in the present in vitro study should be opti-
mized based on data obtained from in vivo disease models
to maximize the throughput.
Conclusions
Using an in vitro disease model, we observed the endothe-
lial dysfunction, such as disorganization and thickening, of
the EC layer. HUVECs cultured on normal collagen films
were thinly adhered to the substrate. By comparison,
HUVECs cultured on denatured collagen films exhibited
abnormal cell growth, such as aggregation and cluster for-
mation of ECs. The expression levels of MMP-1, MMP-2,
and CD146 increased in ECs on the denatured collagen
film. These results indicate that the denatured ECM was
closely related to endothelial dysfunction, which is one of
the main pathogeneses of circulatory vascular diseases.
The morphological structures of the denatured collagen
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fluorescent beads accumulated on the EC layer on the
denatured collagen film. These in vitro studies would be
useful for understanding the outbreak mechanism of
circulatory vascular disorders. In vitro studies using a
bio-inspired ECM could contribute in developing a
unique experimental modality for optimizing the design
parameters to screen effective therapeutic drugs, and
determine the physical dimensions and flow rate condi-
tion of a microfluidic device used for clinical treatments




The substrates of 18 mm round cover glasses (Marlenfeld
GmbH & Co. KG, Lauda-Königshofen, Germany) were
coated with silicon nitride (coating thickness = 200 nm).
The cover slips were then treated with reactive O2
plasma (20 sccm, 200 mTorr, 50 W for 3 min) to simu-
late the morphological structures of normal collagen
films. A methyl-terminated SAM was created at room
temperature by incubating the substrate overnight with
3.78 μL of OTS mixed with 10 mL of anhydrous toluene
solution. The samples were washed with toluene solu-
tion, and baked in an oven at 90°C for 20 min. The sub-
strate was cleaned by sonication in toluene solution for
1 min, washed with 70% ethanol, and dried under nitro-
gen gas stream. To prepare the collagen films on a glass
surface, we diluted 1 mg/mL collagen type I (from rat
tails; Invitrogen, Carlsbad, CA, USA) to a final concen-
tration of 0.32 mg/mL using PBS (pH 7.4) solution,
which contained calcium and magnesium; the resulting
mixture was incubated overnight with previously prepared
methyl-terminated glass at 37°C [69]. The samples were
then washed with PBS solution (without calcium and
magnesium). Collagenase type I (from Clostridium his-
tolyticum; Sigma-Aldrich) was diluted to a final concen-
tration of 2 mg/mL using PBS solution containing calcium
and magnesium. The prepared collagen film surface was
treated for 5 or 15 min to form denatured collagen films
on a glass surface. The collagen and denatured collagen-
conjugated glass surfaces were immediately washed with
PBS solution (without calcium and magnesium). For SEM
imaging, both collagen films were rinsed with deionized
water and dried with nitrogen gas for the analysis of struc-
tural properties. The samples were mounted on metal
stubs and coated with platinum (SC7640 model, Quorum
Technology). SEM images were captured using SEM
(JEOL JSM-7401 F, Japan) at an acceleration voltage of
15 kV. Surface structures of the two films were also ob-
served by AFM (VECO Dimension 3100). The three-
dimensional (3D) reconstruction of AFM images was
performed using Nanoscope V (Version 7.0) software.Based on a previous study by Elliot et al., the collagen
thin film coated on the OTS-SAM-coated glass is amen-
able for use in engineering applications and for manipu-
lating and studying cell behaviors. This reproducible
and analytically tractable collagen matrix provides a
unique tool for the systematical examination of matrix
organization and composition [69].
Cell preparation
All experimental procedures complied with the act on
life ethics and safety of the Ministry of Health and
Welfare of South Korea. HUVECs were obtained from
Invitrogen (Carlsbad, CA, USA) and used in passages 5
or 7. The cells were cultured in Medium 200 (Gibco)
with low-serum growth supplement (Gibco) containing
20% fetal bovine serum (Gibco) and 1% penicillin-
streptomycin (HyClone). The cells were cultured in a
T75 flask (Falcon) under a humidified atmosphere of
5% CO2 at 37°C. Trypsin/ethylenediaminetetraacetic
acid solution was used to detach cells from the culture
flask. The surface-treated cover glass (collagen film or
denatured collagen film) was placed in a cell culture
dish (diameter = 35 mm), loaded with 106 cells/mL cell
suspension, and incubated under a humidified 5% CO2
atmosphere at 37°C. Figures 1A and 1B illustrate the
ECs cultured on the collagen and denatured collagen
films, respectively. HUVECs were cultured on the
collagen film or denatured collagenase-treated collagen
film for 1, 3, 6, 12, and 24 h. For DHM imaging, the
test samples were fixed with 4% paraformaldehyde
solution for 20 min at room temperature, and washed
with PBS solution. Each sample was placed on a drop
of PBS solution at the center of a polydimethylsiloxane
chamber. Sample images were photographed at room
temperature.
Phase-contrast holographic microscopy
He-Ne (λ = 633 nm) laser was used as a light source of
an upright microscope (Eclipse i50, Nikon) equipped
with a 20× objective lens (NA = 0.5). Using additional
relay optics, we set the overall magnification of the
microscope at approximately 30×. Interferograms were
recorded using a charge-coupled device (CCD) camera
(PCO 2000, 7.4 μm/pixel) of 2 k × 2 k pixel resolution.
The transmission-type phase-contrast DHM applied in
this study is based on the principle of the Mach-
Zehnder interferometer. After passing through a spatial
filter, a laser beam was divided into an object beam and
reference beam by a beam splitter. The sample was illu-
minated by the object beam via a condenser lens. A
microscope objective (MO) lens caused the wavefront
in the object beam to form a curved line, which resulted
in the deformation of the object wave phase. The ob-
jective beam was collimated using a collimation lens to
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collimated object wave interfered with the collimated
reference wave at a slightly tilted incidence angle to
generate holograms.
Morphology and surface roughness of EC layer
An angular spectrum algorithm was employed to recon-
struct holograms [43,70,71]. This technique does not
require a minimum distance between the object plane
and hologram plane. The angular spectrum algorithm is
flexible and can be effectively used to filter the frequency
domain with high accuracy. If E0(x0, y0; 0) is the wave field
at plane z = 0, the angular spectrum A(kx, ky; 0) of the
hologram at z = 0 is obtained by Fourier transformation:
A kx; ky; 0
  ¼
ZZ




where kx and ky are the spatial frequencies of the x and y
components, respectively.
The separated zero-order image, virtual image, and
real image were clearly observed in the frequency do-
main. Fourier-domain filtering was applied to the angu-
lar spectrum to eliminate unwanted noises, as well as
the zero-order and virtual images. A region of interest
in the real image was selected using Fourier-domain fil-
tering. The actual image was shifted to the center of the
frequency domain. The complex wave field, recon-
structed at any plane perpendicular to the propagating
z-axis, was then calculated using the following equation:





where filter[ℑ{E0}] denotes the filtered angular spectrum,
and ℑ and ℑ− 1 are the Fourier transform and inverse
Fourier transform, respectively. The reconstructed wave
field E(x,y;z) is represented by an array of complex num-
bers. The amplitude-contrast images were obtained by
calculating the intensity distribution as follows:
I m; nð Þ ¼ Re E x; y; zð Þ½ 2 þ Im E x; y; zð Þ½ 2 ð3Þ
and the phase-contrast image was derived from the fol-
lowing argument values:
ϕ m; nð Þ ¼ arctan Im E x; y; zð Þ½ 
Re E x; yl; zð Þ½ 
 
ð4Þ
The 2π ambiguity encountered in the wrapped phase
image was resolved by the unwrapping process [72]. The
physical thickness of cells was calculated using the
following equation:
d ¼ λ ϕ=2πð Þ= n−n0ð Þ ð5Þwhere λ is the wavelength, ϕ is the unwrapped phase
angle, and (n-n0) is the refractive index difference
between the cells and surrounding medium.
The hologram images of the field-of-view of approxi-
mately 370 μm× 370 μm were captured using a CCD
camera with 1600 × 1600 pixels. Considering that the
refractive index depends on principal components and
different physical states, we discovered that the local
refractive index was slightly different in the EC layer.
The mean refractive index of ECs tested in this study was
approximately 1.375. The stability of the mean refractive
index corresponds to the vertical sensitivity of approxi-
mately 11 nm [42,73,74]. Assuming that the total refract-
ive index of the cells is constant, we applied Equation (5)
to extract information about physical thickness from the
original phase image. The obtained 3D phase image clearly
shows the physical thickness distribution of the EC layer
with high spatial resolution.
The 3D phase images shown in Figures 2D and 2E
illustrate the physical thickness distribution of the EC
layer with high spatial resolution. Variations in the surface
roughness of HUVECs were described mathematically
using root mean square (RMS). The surface roughness









where n is the number of samples, and M is the thick-
ness of the EC layer.
Dynamic behavior of ECs
To observe the dynamic behavior of cell-to-cell inter-
action, we visualized HUVECs cultured on collagen or
collagenase-treated collagen film using CLSM (OLYMPUS
FV-1000). HUVECs’ membranes were labeled with a
PKH26 red fluorescent cell linker kit (Sigma-Aldrich)
and PKH67 green fluorescent cell linker kit (Sigma-
Aldrich) according to the manufacturer’s protocol.
The green- and red-fluorescence-labeled HUVECs were
mixed at a volume ratio of 1:1. These cells were seeded on
collagen film, and incubated under humidified 5% CO2
medium at 37°C. To maintain the standard tissue culture
condition for ECs in the flow chamber, we placed all
the components, except the syringe pump, in a chamber
(Chamlide TC, Live Cell Instrument, Korea) in which the
temperature and CO2 concentration were controlled. The
cell culture medium was continuously circulated (1 mL/h)
over the cells by a syringe pump (KD Scientific). ECs were
cultured on the collagen film or denatured collagenase-
treated collagen film for 3 h, and mounted in the flow
chamber. Cell movements were observed for 90 min at an
interval of 10 min under CLSM.
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The growth properties of HUVECs plated on the treated
and untreated collagen films were analyzed using the
Apoptosis, DNA damage, and Cell Proliferation (ADDCP)
kit (BD Biosciences, USA) and FACS technique. The
ADDCP kit contains key markers [bromodeoxyuridine
(BrdU), H2AX, and PARP] for the simultaneous determin-
ation of important cellular state changes in the cell cycle,
such as apoptosis, DNA damage, and cell proliferation.
BrdU is an analog of the DNA precursor thymidine. When
cells are incubated in the presence of BrdU, the molecule
is incorporated into newly synthesized DNA and can be
detected with antibodies against BrdU [75]. DNA damage
was determined using Phosphorylated H2AX. H2AX is a
member of the histone H2A protein family. Phosphoryl-
ation of H2AX leads to the recruitment of DNA damage
repair proteins at the site of DNA damage [76]. Detection
of cleaved PARP is used for the study of apoptosis. During
the early phases of apoptosis (programmed cell death),
caspase-3 is activated by cleavage [77].
HUVECs were cultured on the collagen film or dena-
tured collagen film for 6, 12, 24, and 36 h. Biological
analyses on apoptosis, DNA damage, and cell prolifera-
tion were performed according to the manufacturer’s
protocol. The test samples were then analyzed using a
BD FACSCanto II flow cytometer (BD Biosciences, USA).
The acquired data were handled with FlowJo (Version
10.0.6) flow cytometry analysis software.MMP-1 and MMP-2 of ECs
MMP-1 (BC013875.2) and MMP-2 (BC002576.2) in the
gateway entry vector were tagged with EGFP or red
fluorescent protein (mCherry) by combining the MMPs
with gateway destination vector (pDS-XB-EGFP or pDS-
XB-mCherry) using LR recombinase (Invitrogen). MMP-1
or MMP-2 vector was mixed with FuGENE HD trans-
fection reagent (Promega). HUVECs were then tagged
with MMP-1/EGFP and MMP-2/mCherry. To visualize
the spatial distribution of MMP-1 or MMP-2 vector on
HUVECs, we cultured HUVECs on collagen or dena-
tured collagenase-treated collagen films for 24 h, and
fixed the cells with 4% paraformaldehyde solution for
20 min at room temperature. ECs were then stained
with DAPI (Invitrogen) for nuclear staining. The stained
EC images were obtained using CLSM (TCS SP5II MP
Leica Microscopy Systems, GMBH) with a 20× IR APO
water-immersion lens (NA 1, Leica Microscopy Systems,
GMBH). The acquired images were analyzed and proc-
essed using LAS AF 2.7 software (Leica Microscopy Sys-
tems, GMBH). MMP2 has difficulty in discriminating
the difference in fluorescence intensity of ECs on the
collagen and denatured collagen films because of their
weak fluorescence intensities. Therefore, we furtherimproved the contrast and brightness of fluorescence
images using Image J software.
Collagen zymography
Collagen zymography assay was performed to detect
MMP-1, −2, −9, and −13 [78,79]. To investigate MMP
activity on the three different collagen films, samples
were centrifuged to dispose cellular debris and then ho-
mogenized without a reducing agent to retain the native
state of the enzyme. Samples were centrifuged once again
at 16,000 g for 20 min at 4°C. The protein concentration
of the collected supernatant was measured by a Nanodrop
Spectrophotometer (Thermo Scientific, Wilmington, DE,
USA). The samples were mixed with an equal volume of
2× non-reducing sample buffer (Santa Cruz Technology,
Santa Cruz, CA, USA), and 15–20 μL was loaded in each
well. Polyacrylamide gels containing 10 mL of type I
collagen (from rat tails; 1 mg/mL, Invitrogen, Carlsbad,
CA, USA) were dispersed in a buffered solution consist-
ing of 2.5 mL of gel, 1.5 M Tris–HCl (pH 8.8), 165 μL of
10% SDS, 5.25 mL of 40% polyacrylamide, 165 μL of
50% glycerol, and 4 mL of distilled water. The stacking
gel containing 4% polyacrylamide in 1 M Tris–HCl
(pH 6.8) was polymerized by adding 100 μL of 10% am-
monium persulfate and 10 μL of TEMED. The gel was
then electrophoresed at a constant voltage of 90 V. The
electrophoresed gel was washed twice in 200 mL of
2.5% Triton X-100 (30 min each) under shaking, and in-
cubated in 100 mM Tris–HCl, 5 mM CaCl2, 0.005%
Brij-35, and 0.001% NaN3 (pH 8.0) for 6–48 h at 37°C.
The gel was stained with 0.25% Coomassie brilliant blue
G-250 (50% methanol, 10% acetic acid) for 1 h at room
temperature and destained (40% methanol, 10% acetic
acid). The gels were incubated for 1 h in 5% methanol
and 7.5% acetic acid, and kept under cellophane at 4°C.
The stained gel images were obtained using a color scan-
ner. The density of MMP bands in the acquired images
was analyzed using Quantity One software (Bio-Rad
Laboratories, Hercules, CA, USA).
Immunostaining of ECs
HUVECs were cultured on collagen film or denatured
collagenase-treated collagen film for 24 h, and fixed with
4% paraformaldehyde solution for 20 min at room
temperature to visualize the spatial distribution of adhe-
sion molecules on HUVECs. The antibodies (5 μg/mL)
for VCAM, E-selectin, CD146, and VE-cadherin (R&D
Systems, USA) were overlaid for 1 h on the EC surface
and washed. The secondary antibody (10 μg/mL) conju-
gated with Alexa Fluor 488 or 594 (Invitrogen) was added
again for 1 h and rinsed. ECs were then stained with
phalloidin tetramethylrhodamine isothiocyanate (Sigma-
Aldrich) or phalloidin-fluorescein (Sigma-Aldrich) for
actin staining and with DAPI (Invitrogen) for nuclear
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CLSM (TCS SP5II MP Leica Microscopy Systems,
GMBH) with a 20× IR APO water-immersion lens (NA
1, Leica Microscopy Systems, GMBH). The acquired
images were analyzed and processed using LAS AF 2.7
software (Leica Microscopy Systems, GMBH).
Bead accumulation on the EC layer
A syringe pump (KDS100: KD Scientific), syringe filled with
1 mL of Medium 200 (microsphere density in medium:
9.1 × 107 particles/mL) mixed with yellow-green fluorescent
beads (FluoSpheres Collagen I-Labeled Microspheres,
1.0 μm), and rectangular flow chamber (Chamlide CF,
Live Cell Instrument, Korea) were serially connected to
silicon tubes (inner diameter/outer diameter = 1.15 mm/
3.2 mm, Korea Ace) to examine the effect of flow on bead
accumulation over HUVEC layers. The test channel in the
flow chamber had a height, width, and length of 0.2, 2,
and 14 mm, respectively. To maintain the standard tissue-
culture conditions (37°C, 5% CO2) in the flow chamber
for ECs, we placed the components, except the syringe
pump, in the temperature and CO2 control chamber
(Chamlide TC, Live Cell Instrument, Korea). The ECs cul-
tured on collagen film or denatured collagenase-treated
collagen film for 24 h were mounted in the flow chamber.
Dynamic motions of the motile beads in the flow chamber
were observed using CLSM (OLYMPUS FV-1000) while
recording the bead accumulation process on the HUVEC
layers. A modified Zeiss Axiovert 200 fluorescence micro-
scope with a 20× (NA = 0.4) phase-contrast objective lens
and AxioCam MRc CCD camera was used to monitor the
temporal variation in bead accumulation on the HUVEC
layers. An X-Cite 120 Q excitation light source (120 W
mercury vapor short arc lamp) and shift-free filter set for
GFP/RFP were used in the fluorescence imaging experi-
ment. The microscope was operated by Axiovision 4.8.2
(Carl Zeiss). Captured images were analyzed and proc-
essed using Image-Pro Plus 7.0 software. The dynamic
motions of the motile beads inside the flow chamber were
observed by time-lapse microscopy for 10 min. Images
were consecutively recorded at an interval of 1 s.
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